{"nct_id":"NCT01830972","title":"An Open Label Phase 2 Extension Study of Higher Dose Sialic Acid-Extended Release (SA-ER) Tablets and Sialic Acid-Immediate Release (SA-IR) Capsules in Patients With Glucosamine (UDP-N-acetyl)-2-Epimerase (GNE) Myopathy","status":"COMPLETED","status_verified_date":"2018-03","start_date":"2013-06-04","start_date_type":"ACTUAL","primary_completion_date":"2017-02-14","primary_completion_date_type":"ACTUAL","completion_date":"2017-02-14","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["RARE"]}